DermTech (DMTKQ)
(Delayed Data from OTC)
$0.01 USD
+0.01 (104.29%)
Updated Aug 16, 2024 03:55 PM ET
3-Hold of 5 3
C Value C Growth A Momentum B VGM
Balance Sheet
Fiscal Year End for DermTech, Inc falls in the month of December.
All items in Millions except Per Share data.
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | 56 | 126 | 225 | 64 | 15 |
Receivables | 3 | 4 | 4 | 1 | 1 |
Notes Receivable | 0 | 0 | 0 | 0 | 0 |
Inventories | 1 | 2 | 0 | 0 | 0 |
Other Current Assets | 2 | 4 | 3 | 2 | 1 |
Total Current Assets | 62 | 136 | 233 | 67 | 17 |
Net Property & Equipment | 5 | 6 | 5 | 3 | 1 |
Investments & Advances | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Assets | 0 | 0 | 0 | 0 | 0 |
Deferred Charges | 0 | 0 | 0 | 0 | 0 |
Intangibles | 0 | 0 | 0 | 0 | 0 |
Deposits & Other Assets | 3 | 4 | 3 | 0 | 0 |
Total Assets | 122 | 202 | 248 | 70 | 18 |
Liabilities & Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Notes Payable | 0 | 0 | 0 | 0 | 0 |
Accounts Payable | 1 | 2 | 3 | 2 | 2 |
Current Portion Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | 0 | 0 | 0 | 0 | 0 |
Accrued Expenses | 9 | 11 | 6 | 3 | 1 |
Income Taxes Payable | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities | 0 | 0 | 1 | 1 | 3 |
Total Current Liabilities | 13 | 16 | 12 | 5 | 6 |
Mortgages | 0 | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | 0 | 0 | 0 | 1 | 0 |
Convertible Debt | 0 | 0 | 0 | 0 | 0 |
Long-Term Debt | 0 | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | 0 | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | 0 | 0 | 0 | 0 | 0 |
Minority Interest (Liabilities) | 0 | 0 | 0 | 0 | 0 |
Total Liabilities | 65 | 70 | 19 | 6 | 6 |
Shareholders Equity | 12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 |
---|---|---|---|---|---|
Preferred Stock | 0 | 0 | 0 | 0 | 0 |
Common Stock (Par) | 0 | 0 | 0 | 0 | 0 |
Capital Surplus | 481 | 456 | 436 | 190 | 104 |
Retained Earnings | -424 | -323 | -206 | -126 | -91 |
Other Equity | 0 | -1 | 0 | 0 | 0 |
Treasury Stock | 0 | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | 57 | 132 | 230 | 63 | 12 |
Total Liabilities & Shareholder's Equity | 122 | 202 | 248 | 70 | 18 |
Total Common Equity | 57 | 132 | 230 | 63 | 12 |
Shares Outstanding | 34.20 | 30.20 | 29.70 | 20.70 | 12.30 |
Book Value Per Share | 1.67 | 4.38 | 7.73 | 3.07 | 1.02 |
Fiscal Year End for DermTech, Inc falls in the month of December.
All items in Millions except Per Share data.
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Assets | |||||
Cash & Equivalents | -99,999 | 39 | 56 | 68 | 86 |
Receivables | NA | 3 | 3 | 4 | 4 |
Notes Receivable | NA | 0 | 0 | 0 | 0 |
Inventories | NA | 1 | 1 | 1 | 1 |
Other Current Assets | NA | 2 | 2 | 3 | 2 |
Total Current Assets | NA | 44 | 62 | 76 | 94 |
Net Property & Equipment | NA | 5 | 5 | 6 | 6 |
Investments & Advances | NA | 0 | 0 | 0 | 0 |
Other Non-Current Assets | NA | 0 | 0 | 0 | 0 |
Deferred Charges | NA | 0 | 0 | 0 | 0 |
Intangibles | NA | 0 | 0 | 0 | 0 |
Deposits & Other Assets | NA | 3 | 3 | 3 | 3 |
Total Assets | NA | 103 | 122 | 138 | 157 |
Liabilities & Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Notes Payable | NA | 0 | 0 | 0 | 0 |
Accounts Payable | NA | 2 | 1 | 2 | 2 |
Current Portion Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Current Portion Capital Leases | NA | 0 | 0 | 0 | 0 |
Accrued Expenses | NA | 7 | 9 | 8 | 11 |
Income Taxes Payable | NA | 0 | 0 | 0 | 0 |
Other Current Liabilities | NA | 0 | 0 | 0 | 0 |
Total Current Liabilities | NA | 13 | 13 | 13 | 16 |
Mortgages | NA | 0 | 0 | 0 | 0 |
Deferred Taxes/Income | NA | 0 | 0 | 0 | 0 |
Convertible Debt | NA | 0 | 0 | 0 | 0 |
Long-Term Debt | NA | 0 | 0 | 0 | 0 |
Non-Current Capital Leases | NA | 0 | 0 | 0 | 0 |
Other Non-Current Liabilities | NA | 0 | 0 | 0 | |
Minority Interest (Liabilities) | NA | 0 | 0 | 0 | 0 |
Total Liabilities | NA | 63 | 65 | 65 | 69 |
Shareholders Equity | 6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 |
---|---|---|---|---|---|
Preferred Stock | NA | 0 | 0 | 0 | 0 |
Common Stock (Par) | NA | 0 | 0 | 0 | 0 |
Capital Surplus | NA | 484 | 481 | 478 | 474 |
Retained Earnings | NA | -444 | -424 | -405 | -386 |
Other Equity | NA | 0 | 0 | 0 | 0 |
Treasury Stock | NA | 0 | 0 | 0 | 0 |
Total Shareholder's Equity | NA | 40 | 57 | 73 | 88 |
Total Liabilities & Shareholder's Equity | NA | 103 | 122 | 138 | 157 |
Total Common Equity | 0 | 40 | 57 | 73 | 88 |
Shares Outstanding | 34.90 | 34.60 | 34.20 | 34.20 | 33.60 |
Book Value Per Share | 0.00 | 1.16 | 1.67 | 2.14 | 2.62 |